Genetic

20.10.2022 • News

Lilly Acquires Hearing Loss Specialist Akouos

Lilly has agreed to acquire Akouos, a precision genetic medicine company that is developing gene therapy treatments for hearing loss. Both companies’ boards have approved the deal, which is expected to close in the fourth quarter and cost Lilly up to $610 million.

27.05.2016 • News

UK and US Scientists See no Harm in GM

04.04.2016 • Topics • Strategy

The Art of the Alliance

07.10.2015 • Topics • Strategy

The Future Lies in the Genome

16.11.2014 • News

Dow to Restrict GM Corn, Soybeans Sales Pending Chinese OK

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Bayer AG

SchüllerConsulting